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990Comparative effectiveness study of self-directed
walking exercise, lower extremity revascularization,
and functional decline in peripheral artery disease
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Lu Tian, ScD,c Yihua Liao, MS,a Lihui Zhao, PhD,a and Michael H. Criqui, MD, MPH,d Chicago, Ill;
Baltimore, Md; and Stanford and San Diego, Calif
Objective: Among individuals with peripheral artery disease (PAD), we compared annual change in 6-minute walk
performance between participants who neither underwent lower extremity revascularization nor walked for exercise
(group 1, reference), those who walked regularly for exercise (group 2), and those who underwent lower extremity
revascularization (group 3).
Methods: Participants were recruited from Chicago-area vascular laboratories and followed annually. Change in 6-minute
walk was calculated beginning at the study visit preceding lower extremity revascularization or exercise behavior and
continuing for 1 additional year after the therapy was reported. Results are adjusted for age, sex, race, comorbidities, and
other confounders.
Results: Of 348 PAD participants, 43 underwent revascularization during median follow-up of 84 months. Adjusted
annual declines in 6-minute walk were L96.6 feet/year for group 1, L49.9 feet/year for group 2, andL32.6 feet/year
for group 3 (P < .001). Forty-one percent of revascularizations were not associated with ankle-brachial index (ABI)
improvement. When group 3 was limited to participants with ABI improvement $0.15 after revascularization, annual
adjusted changes in 6-minute walk wereL97.7 feet/year for group 1,L46.5 feet/year for group 2, andD68.1 feet/year
for group 3 (P < .001). When group 3 was limited to participants without ABI improvement$0.15 after revascularization,
annual adjusted changes in 6-minute walk were L99.2 feet/year for group 1, L48.0 feet/year for group 2, and L61.7
feet/year for group 3 (P < .001).
Conclusions: A large proportion of PAD participants did not have ABI improvement of at least 0.15 at follow-up study
visit after revascularization. The beneﬁts of lower extremity revascularization in patients with PAD appear closely tied to
improvements in the ABI after revascularization. (J Vasc Surg 2013;57:990-6.)Men and women with lower extremity peripheral arte-
rial disease (PAD) have greater functional impairment and
faster rates of functional decline compared with people
without PAD.1-3 Rates of lower extremity revascularization
and related medical care costs are increasing.4 The Institute
of Medicine has identiﬁed PAD as among the high-priority
medical conditions in need of comparative effectiveness
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://dx.doi.org/10.1016/j.jvs.2012.09.068The Walking and Leg Circulation Study (WALCS)
cohort is a longitudinal natural history study of men and
women with PAD followed for up to 8 years.1-3 The
primary aim of the current study was to compare average
annual decline in 6-minute walk among PAD participants in
the WALCS cohort according to whether they (1) reported
neither lower extremity revascularization nor engaged
in walking exercise during follow-up (group 1, reference
group); (2) reported that they engaged in regular walking
exercise (group 2); or (3) reported lower extremity revas-
cularization during follow-up (group 3). We hypothesized
that PAD participants who participated in regular walking
exercise and those who underwent lower extremity revas-
cularization, respectively, would experience less annual
decline in 6-minute walk performance compared with
participants who neither underwent lower extremity revas-
cularization nor engaged in walking exercise. Average
annual decline in 4-meter walking velocity was a secondary
outcome. In secondary aims, we repeated our analyses,
limiting the revascularized group ﬁrst to participants with
an ankle-brachial index (ABI) increase $0.15 in the revas-
cularized leg and then to participants without an ABI
increase $0.15 in the revascularized leg. Our results
provide real-world information on the relative beneﬁts of
self-directed walking exercise and lower extremity revascu-
larization among men and women with PAD.
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Methods for the WALCS longitudinal observa-
tional study of men and women with PAD have been
described.1-3 The protocol was approved by the Institu-
tional Review Board of Northwestern University and
participating medical centers.
Participant identiﬁcation. Participants were age 55
years or older at baseline and were identiﬁed from among
consecutive patients diagnosed with PAD in three Chicago-
area noninvasive vascular laboratories. In order to be
eligible for WALCS, PAD participants were required to have
been diagnosed with PAD in one of the noninvasive vascular
laboratories and have an ABI <0.90 at their baseline study
visit. A small number of PAD participants were identiﬁed
from among consecutive patients in a large general medicine
practice who were screened for PAD with the ABI. Baseline
visits occurred between October 1998 and January 2000.
Follow-up visits occurred annually for up to 9 years. Data
collection at baseline and at annual follow-up visits included
a detailed medical history, conﬁrmed with medical record
review, 6-minute walk and 4-meter walking velocity
measures, and the ABI. PAD was deﬁned as ABI <0.90 at
the baseline study visit.1-3
Exclusion criteria. Exclusion criteria have been re-
ported.3 Patients with dementia, recent major surgery, or
foot or leg amputations were excluded. Nursing home
residents and wheelchair-bound patients were excluded.
Non-English-speaking patients were excluded because in-
vestigators were not ﬂuent in non-English languages.
ABI measurement. A hand-held Doppler probe
(Nicolet Vascular Pocket Dop II, Golden, Colo) was used
to obtain systolic pressures in the right and left brachial,
dorsalis pedis, and posterior tibial arteries at baseline and at
each follow-up visit.1-3 Each pressure was measured twice.
The ABI was calculated in each leg by dividing the average
of the dorsalis pedis and posterior tibial pressures in each
leg by the average of the left and right brachial pressures.6
Average brachial pressures in the arm with the highest
pressure were used in the denominator when one brachial
pressure was higher than the opposite brachial pressure in
both measurement sets, and the two brachial pressures
differed by $10 mm Hg in at least one measurement set,
because in such cases, subclavian stenosis was possible.7
The lowest leg ABI was used in analyses. An ABI <0.90
was required at the baseline visit for inclusion.
Comorbidities. Algorithms developed for theWomen’s
Health and Aging Study were used to document angina, dia-
betes, myocardial infarction, stroke, heart failure, pulmo-
nary disease, spinal stenosis, disk disease, and hip fracture.8
American College of Rheumatology criteria were used to
diagnose knee and hip osteoarthritis.9,10
Functional measures
Six-minute walk. Following a standardized protocol,1-3
participants walk up and down a 100-foot hallway for 6
minutes after instructions to cover as much distance as
possible.Four-meter walking velocity. Walking velocity was
measured with a 4-meter walk performed at “usual” and
“fastest” pace. For the “usual” paced walk, participants were
instructed to walk at their usual pace, “as if going down the
street to the store.” Each walk was performed twice. The
faster walk in each pair was used in analyses.1-3
Self-reported exercise. At baseline and each annual
follow-up visit, participants were asked, “During the past
2 weeks, have you gone walking for exercise?” Participants
who answered “yes” were queried about the number of
walking exercise sessions they engaged in during the past
2weeks and the duration ofwalking exercise for each session.
We classiﬁed participants as engaging in regular walking
exercise (group 2) if they described walking exercise activity
at least three times per week for a total of at least 90 minutes
per week.11
Ascertainment of lower extremity revasculariza-
tion. At each annual follow-up visit, participants were
asked, “Since your last WALCS visit on <date>, did you
have a procedure to improve the blood ﬂow to your legs?”
Medical records were obtained and abstracted by a physi-
cian to identify lower extremity revascularizations after the
baseline visit. A primary care physician questionnaire was
also mailed after each study visit to identify and verify lower
extremity revascularization since the previous study visit.
The presence of lower extremity revascularization required
documentation in the medical record or conﬁrmation by
the primary care physician.
An ABI increase of at least 0.15 in the revascularized
leg at the study visit immediately after revascularization
was considered a clinically meaningful ABI improvement.
An ABI increase <0.15 in the revascularized leg at the
study visit immediately after revascularization was consid-
ered not to have had a clinically meaningful improvement
in ABI after revascularization.
Leg symptoms. Leg symptoms were classiﬁed into
one of ﬁve groups using the San Diego Claudication Ques-
tionnaire, based on previous study as follows1,2,12: (1)
intermittent claudication (exertional calf pain that does not
begin at rest and resolves within 10 minutes after walking
ceases); (2) leg pain on exertion and rest (exertional leg
pain that sometimes begins at rest); (3) atypical exertional
leg pain/carry on (exertional leg symptoms that do not
begin at rest and do not stop the individual while walking);
(4) atypical exertional leg pain/stop (exertional leg symp-
toms that do not meet criteria for the other three symptom
groups); or (5) asymptomatic (no pain in either leg or
buttock on walking).
Other measures. Height and weight were measured at
each visit. Body mass index (BMI) was calculated as weight
(kilograms)/height (meters).2 Cigarette smoking (pack-
years) was assessed annually with self-report. Physical activity
was measured using a validated measure of patient-reported
blocks walked in the past week.13
Follow-up. Individuals for whom data collection forms
indicated that the participant was unable to complete func-
tional measures at follow-up due to wheelchair conﬁnement,
exhaustion, or other signiﬁcant symptoms were classiﬁed as
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developed algorithm incorporating participant-reported
physical activity and performance on standing balance tests
and time for ﬁve repeated chair rises was used to classify
participants who refused functional measures at follow-up
into “disabled” or “nondisabled.”2 Those classiﬁed as
“disabled” were assigned the minimum score of all partici-
pants who completed the 6-minute walk or 4-meter walking
velocities at the study visit for which they were classiﬁed as
disabled.2
Statistical analyses. At each follow-up visit, partici-
pants were categorized into group 1 (no revascularization
and no regular walking exercise since the last visit, refer-
ence), group 2 (self-reported regular walking exercise since
the last visit), and group 3 (report of lower extremity
revascularization since the last visit). Participants who re-
ported both revascularization and walking exercise at
a follow-up visit were classiﬁed in group 3. Baseline char-
acteristics across these three groups were compared using
general linear models for continuous variables and c2 tests
for categorical variables.
In comparing change in 6-minute walk distance across
the groups, a longitudinal or repeated measures analysis
of covariance was carried out using mixed-effects linear
regression analysis, adjusting for age, sex, race, BMI, ABI,
comorbidities, smoking, leg symptoms, and functional per-
formance at the immediately preceding study visit. Group
status was entered into the model as a time-dependent vari-
able. For example, when revascularization was reported at
the ﬁrst annual follow-up visit (FV-1), change in 6-minute
walk associated with revascularization was evaluated by the
average annual change in 6-minute walk between the second
annual follow-up visit (FV-2) and the visit occurring 1 year
before FV-1, when revascularization was reported. When
regular walking exercise was reported at FV-2, change in
6-minute walk associated with walking exercise was evalu-
ated by the average annual change in 6-minute walk
between the third-annual follow-up visit (FV-3) and the
visit occurring 1 year before FV-2 (ie, FV-1). Analyses
were performed using person-years of follow-up. Thus,
individuals contributed multiple person-years of follow-
up, for example, if they were categorized into group 1
(reference) at their FV-1 visit but reported lower extremity
revascularization at their FV-3 visit.
Longitudinal analyses were repeated (1) after restrict-
ing group 3 to participants whose ABI in the revascularized
leg increased by at least 0.15 at the study visit immediately
after revascularization compared to the ABI in the same leg
at the study visit immediately before revascularization and
(2) after restricting group 3 to participants whose ABI
in the revascularized leg did not increase by at least
0.15 at the study visit immediately after revascularization
compared to the ABI in the same leg at the study visit
immediately before revascularization. If a participant un-
derwent bilateral revascularization, the leg with the lowest
ABI before revascularization was considered in analyses
because prior study shows that the ABI in the leg with
the lowest ABI is more closely associated with the degreeof functional impairment than is the leg with higher
ABI.6 Of the 25 participants with bilateral lower extremity
revascularization, only three participants had an ABI
increase $0.15 in the leg with highest ABI without
a concomitant increase >0.15 in the leg with lowest ABI
before revascularization. For all longitudinal analyses, pair-
wise comparisons were also performed, comparing group 2
and group 3, respectively, to group 1. Analyses were per-
formed using SAS statistical software (version 9.1; SAS
Institute Inc, Cary, NC).
RESULTS
Of 460 PAD participants in the WALCS cohort, 35
were missing information about exercise behavior and
76 were missing data on functional performance during
follow-up, leaving 349 participants. Of these, one was
missing data for BMI, leaving 348 eligible participants for
analyses. Compared with potential participants who were
missing data on functional performance during follow-up,
those included in analyses had a higher BMI (27.6 vs
26.1 kg/M2; P ¼ .005) and lower prevalences of heart
failure (24.4% vs 38.4%; P ¼ .004), pulmonary disease
(30.0% vs 42.0%; P ¼ .018), and cancer (12.9% vs 25.9%;
P ¼ .001).
Of the 348 PAD participants, the average age was
71.45 6 8.47 years, 60.3% were male, 15.8% were African
American, 21.3% were current smokers, and 30.5% had dia-
betes mellitus. Eighty-two percent had any exertional leg
symptoms, and 32.5% had classic claudication symptoms.
Mean ABI among the 348 participants was 0.65 6 0.15.
Forty-three of the 348 PAD participants underwent 61 lower
extremity revascularization procedures during follow-up
(group 3), 160 did not undergo revascularization but re-
ported self-directed walking exercise during at least one
follow-up visit (group 2), and 145 reported neither therapy
at any follow-up visits (group 1, reference). PAD participants
who underwent revascularization (group 3) were younger
and had lower baseline BMI compared with participants in
the other two groups. PAD participants who engaged in
regular self-directed walking exercise (group 2) included
lower proportions of current smokers and African American
participants compared with the other groups (Table I).
The ABI data were collected both before and after 54
of the 61 revascularization procedures. Of these, 39
revascularizations (72%) were associated with an ABI
increase <0.15 at the study visit immediately after revascu-
larization. Overall, the mean ABI change in legs under-
going revascularization was þ0.061 6 0.24. Mean change
in the lowest leg ABI among participants who engaged in
regular exercise was –0.01 6 0.13, and mean change in
the lowest leg ABI among participants who neither engaged
in regular exercise nor underwent lower extremity revascu-
larization was þ0.01 6 0.16.
Overall, average annual declines in 6-minute walk
were 96.6 feet in group 1 (no revascularization or exer-
cise), –49.9 feet in group 2 (self-directed walking exercise),
and –32.6 feet in group 3 (participant-reported revascular-
ization; P < .001), adjusting for age, sex, race, prior year
Table I. Baseline characteristics of PAD participants according to treatment during follow-up
Neither revascularization
nor walking exercise
during follow-upa
Exercise $ three times
per week during follow-upb
Lower extremity
revascularization
during follow-upc P value
N 145 160 43
Age, years (SD) 70.92 (8.66) 72.60 (8.19) 68.91 (8.29) .024
ABI (SD) 0.65 (0.16) 0.67 (0.13) 0.61 (0.14) .069
BMI, kg/M2 (SD) 27.95 (5.31) 27.67 (4.19) 25.83 (4.07) .032
Male gender, % 59.3 61.3 60.5 .942
African American, % 21.4 10.0 18.6 .021
Current smoker, % 27.6 15.0 23.3 .026
Diabetes, % 33.1 28.8 27.9 .660
Angina, % 37.9 31.3 41.9 .302
Myocardial infarction, % 28.3 26.9 16.3 .279
Stroke, % 12.4 9.4 16.3 .408
Heart failure, % 26.9 25.6 11.6 .110
Cilostazol, % 0.7 1.3 4.7 .195
Pentoxifylline, % 8.3 6.9 4.7 .706
Classic IC, % 28.3 33.1 44.2 .143
ABI, Ankle-brachial index; BMI, body mass index; IC, intermittent claudication ; PAD, peripheral arterial disease; SD, standard deviation.
aParticipants in this group reported neither regular self-directed walking exercise nor lower extremity revascularization at any annual visit during follow-up.
bParticipants included in this group reported engaging in walking exercise at least once during follow-up and did not report lower extremity revascularization
during follow-up.
cParticipants in this group reported lower extremity revascularization at least once during follow-up.
A
B
Fig. Associations of walking exercise, lower extremity revascularization, and neither therapy with average annual
change in 6-minute walk performance. A, Revascularization group is restricted to participants whose ankle-brachial
index (ABI) improved after revascularization. B, Revascularization group is restricted to participants whose ABI was
unchanged or declined after revascularization.
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and leg symptoms. Among participants in group 3,
the correlation between change in ABI and change in
6-minute walk after revascularization was 0.528 (P <
.001). In contrast, there was no association of change in
ABI and change in 6-minute walk among group 2(correlation coefﬁcient ¼ –0.017; P ¼ .716) or group 1
patients (correlation coefﬁcient ¼ –0.009; P ¼ .792).
When analyses were repeated after restricting group 3 to
participants whose ABI improved by at least 0.15 after
revascularization, group 3 had greater improvement in
the 6-minute walk compared with group 1 (P ¼ .003)
Table II. Adjusted associations of regular self-directed walking exercise and lower extremity revascularization with
average change in walking velocity among participants with PADa
Group 1b Group 2c Group 3d
P valueNo revascularization or exercise
Regular self-directed
walking exercise
Lower extremity
revascularization
Usual pace 4-meter walking velocity (m/s)
All participants e0.062 (e0.074 to e0.049) e0.047 (e0.063 to e0.032) e0.061 (e0.094 to e0.028) .2164
Group 2 restricted to
participants with ABI
improvement after
revascularization
e0.063 (e0.077 to 0.050) e0.049 (e0.065 to e0.032) e0.059 (e0.124 to e0.006) .2262
Group 2 restricted to
participants with no
ABI improvement
after revascularization
e0.063 (e0.076 to e0.051) e0.049 (e0.064 to e0.033) e0.050 (e0.090 to e0.009) .1991
Fastest pace 4-meter walking velocity (m/s)
All participants e0.094 (e0.112 to e0.076) e0.072 (e0.094 to e0.051) e0.071 (e0.117 to e0.025) .1393
Group 2 restricted to
participants with ABI
improvement after
revascularization
e0.096 (e0.114 to 0.078) e0.075 (e0.098 to 0.053) e0.079 (e0.166 to e0.009) .1968
Group 2 restricted to
participants with no
ABI improvement
after revascularization
e0.097 (e0.115 to e0.079) e0.074 (e0.096 to e0.052)e e0.064 (e0.120 to e0.008) .0996
ABI, Ankle-brachial index; BMI, body mass index; PAD, peripheral arterial disease.
aAnalyses adjusted for age, sex, race, prior year performance, ABI, BMI, smoking, comorbidities, and leg symptoms.
bNo revascularization or exercise.
cRegular self-directed walking exercise.
dLower extremity revascularization.
eThe difference between groups 1 and 2 is statistically signiﬁcant (P ¼ .049).
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engaging in regular walking exercise (group 2) had less 6-
minute walk decline than did participants in group 1 (P ¼
.0002; Fig A).
When adjusted analyses were repeated after restricting
group 3 to PAD participants whose ABI did not improve
by at least 0.15 after revascularization, adjusted annual
decline in 6-minute walk performance was greatest in
group 1 and least in group 2 (P < .001; Fig, B). In pairwise
analyses, PAD participants who engaged in self-directed
walking exercise (group 2) had less 6-minute walk decline
than did participants in group 1 (P < .001; Fig, B).
Adjusting for age, sex, race, prior year performance,
ABI, BMI, smoking, comorbidities, and leg symptoms,
there were no signiﬁcant differences in the average annual
change in the usual paced or fastest-paced 4-meter walking
velocity between groups 1, 2, and 3 (Table II). When anal-
yses were repeated after restricting group 3 to participants
with ABI improvement of at least 0.15 after revasculariza-
tion and to participants without an ABI improvement of at
least 0.15 after revascularization, results were similar to
those for the entire group (Table II).
Of the 61 revascularization procedures, 21 were
classiﬁed as surgical and 27 as endovascular procedures.
Four procedures were a hybrid of endovascular and surgical
revascularization. Medical record data were insufﬁcient
to classify procedure type for nine revascularizations
(Supplementary Table, online only). When analyses wererepeated, limiting group 3 to surgical revascularization
procedures, average annual declines in 6-minute walk
were –98.6 feet in group 1, –46.9 feet in group 2, and
–34.0 feet in group 3, adjusting for age, sex, race, prior
year performance, ABI, BMI, smoking, comorbidities,
and leg symptoms (P < .001). When group 3 was limited
to endovascular procedures, the overall average annual
declines in 6-minute walk were –98.7 feet in group 1,
–46.4 feet in group 2, and –45.5 feet in group 3 (P <
.001).
Results for our primary analyses did not substantially
differ when analyses were repeated using propensity scoring
to adjust for differences in the three groups at baseline
(data not shown). Our results did not substantially differ
when analyses were repeated, imputing missing data for
participants who did not complete follow-up testing (data
not shown).
DISCUSSION
Few therapies are available for improving lower
extremity functional impairment in men and women with
PAD. Only two medications are approved by the United
States Food and Drug Administration for treating PAD-
related walking impairment, and one is no better than
a placebo.14,15 Although supervised treadmill walking exer-
cise improves functional performance in PAD, medical
insurance typically does not pay for supervised treadmill
exercise for patients with PAD.16,17 Thus, most PAD
JOURNAL OF VASCULAR SURGERY
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lower extremity revascularization head to head with
walking exercise are relatively few in number, are limited
to those meeting eligibility criteria, and have yielded incon-
sistent results.19-22 Real-life data on actual changes in lower
extremity functioning after lower extremity revasculariza-
tion among PAD participants not enrolled in randomized
controlled clinical trials are lacking.
Results reported here demonstrate that 72% of revascu-
larization procedures were not associated with at least
a 0.15-unit improvement in ABI and 41% were not associ-
ated with any improvement in the ABI in the ipsilateral leg
at the study visit immediately after revascularization. The
PAD participants with revascularization that was associated
with an ABI improvement of at least 0.15 had signiﬁ-
cantly greater improvement in 6-minute walk performance
compared with PAD participants who engaged in regular
self-directed walking exercise (group 2) and compared
with PAD participants who engaged in neither therapy
(group 1). However, PAD participants with revasculariza-
tion that was not associated with ABI improvement of at
least 0.15 had no signiﬁcant difference in the average
annual change in 6-minute walk compared with group 1.
The PAD participants who engaged in regular self-
directed walking exercise (group 2) had less decline in
the 6-minute walk compared with PAD participants who
engaged in neither therapy (group 1). Together, these
ﬁndings were consistent with our a priori hypotheses.
The high proportion of PAD participants whose ABI did
not improve by at least 0.15 after revascularization was
unexpected. It is conceivable that these participants may
have had rapid ABI declines that were not captured by
the annual study visits but led to immediate revasculariza-
tion. It also is possible that the initial improvement in
ABI after revascularization was followed by an ABI decline
before the next annual study visit.
Our study has limitations. First, the observational study
design prevents deﬁnitive conclusions because selection
bias is likely to inﬂuence treatment decisions in PAD.
Second, deterioration in functional performance or the
ABI that occurred after an annual WALCS visit but imme-
diately before revascularization was not measured. Third,
we do not have data on indications for lower extremity
revascularization. Fourth, our data, collected between
1998 and 2004, may be less applicable to lower extremity
revascularization procedures performed currently. Fifth, we
did not collect data on the technical success of the opera-
tion, measured by change in the ABI immediately after
revascularization. Sixth, our results regarding self-directed
walking exercise may be less favorable than what might
be achieved in supervised treadmill walking exercise.23CONCLUSIONS
Our data suggest that the beneﬁts of lower extremity
revascularization in patients with PAD may be closely
tied to improvements in the ABI after revascularization.
Our results support the beneﬁts of self-directed exercise.Kiang Liu, PhD, of Northwestern University Feinberg
School of Medicine and Luigi Ferrucci, MD, PhD, made
important contributions to this work and to the manuscript.
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Supplementary Table (online only). Types of lower
extremity revascularization procedures
Procedure
No. of
procedures
Endovascular procedures
Angioplasty, not otherwise speciﬁed 5
Angioplasty þ stent, not otherwise speciﬁed 8
Femoral angioplasty 1
Femoral angioplasty and stent 4
Iliac angioplasty 3
Iliac angioplasty with stent 7
Aortic stent 2
Angioplasty with endarterectomy 1
Surgical revascularization procedures
Bypass surgery, not otherwise speciﬁed 5
Anterior tibial bypass surgery 1
Aortofemoral bypass surgery 2
Axillary femoral bypass surgery 2
Femoropopliteal bypass surgery 8
Femoral bypass surgery, not otherwise speciﬁed 1
Iliofemoral bypass surgery 1
Popliteal-to-posterior tibial bypass surgery 1
Bypass to anterior tibial artery 1
Femorotibial bypass 1
Femorofemoral bypass surgery with
endarterectomy
1
Femorofemoral bypass graft 1
Other revascularizations 2
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